Joerg Buddenkotte

Doha, DA, Qatar

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Chronic prurigo in an adolescent patient successfully controlled with dupilumab.

Chronic prurigo in an adolescent patient successfully controlled with dupilumab.

Journal: Skin health and disease

Published: March 10, 2026

Involvement of B Cell Subsets in Patients With Steven Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).

Involvement of B Cell Subsets in Patients With Steven Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).

Journal: Allergy

Published: October 27, 2025

Microdialysis-based metabolomic and proteomic profiling reveals signature variations for disease severity in psoriasis.

Microdialysis-based metabolomic and proteomic profiling reveals signature variations for disease severity in psoriasis.

Journal: The Journal of investigative dermatology

Published: September 25, 2025

Misregulation of T-box transcription factors drives BNP-NPR1 signalling underlying chronic itch.

Misregulation of T-box transcription factors drives BNP-NPR1 signalling underlying chronic itch.

Journal: Nature communications

Published: August 04, 2025

Basophil activity in atopic dermatitis: Distinct immunomodulatory roles of dupilumab and abrocitinib.

Basophil activity in atopic dermatitis: Distinct immunomodulatory roles of dupilumab and abrocitinib.

Journal: The Journal of investigative dermatology

Published: July 28, 2025

Dermatitis herpetiformis successfully treated with dupilumab.

Dermatitis herpetiformis successfully treated with dupilumab.

Journal: JAAD case reports

Published: June 23, 2025

Three cases of chronic photodermatitis successfully treated with upadacitinib.

Three cases of chronic photodermatitis successfully treated with upadacitinib.

Journal: Skin health and disease

Published: May 29, 2025

The Neurogenic Inflammation Mediator Endothelin-1 Causes Human Skin Barrier Disruption in Atopic Dermatitis via an ETAR/TRPA1-Axis.

The Neurogenic Inflammation Mediator Endothelin-1 Causes Human Skin Barrier Disruption in Atopic Dermatitis via an ETAR/TRPA1-Axis.

Journal: Allergy

Published: April 30, 2025

TDP-43 proteinopathies and neurodegeneration: insights from Caenorhabditis elegans models.

TDP-43 proteinopathies and neurodegeneration: insights from Caenorhabditis elegans models.

Journal: The FEBS journal

Published: April 04, 2025

Sanguinarine Induces ROS-Mediated Mitochondrial Dysfunction and Inhibits AKT/GSK3 Signaling to Potentiate Apoptotic Effects in Cutaneous T-Cell Lymphoma.

Sanguinarine Induces ROS-Mediated Mitochondrial Dysfunction and Inhibits AKT/GSK3 Signaling to Potentiate Apoptotic Effects in Cutaneous T-Cell Lymphoma.

Journal: Phytotherapy research : PTR

Published: March 28, 2025

Curcumin induces apoptosis via downregulation of SKP2 and induction of GADD45A/CDKN1A expression through generation of ROS in cutaneous T-cell lymphoma cells.

Curcumin induces apoptosis via downregulation of SKP2 and induction of GADD45A/CDKN1A expression through generation of ROS in cutaneous T-cell lymphoma cells.

Journal: Toxicology and applied pharmacology

Published: March 12, 2025

Targeting FOXM1 regulates metabolic signatures through ROS-dependent JNK/Bmi1/Skp2 axis in human cutaneous T-cell lymphoma.

Targeting FOXM1 regulates metabolic signatures through ROS-dependent JNK/Bmi1/Skp2 axis in human cutaneous T-cell lymphoma.

Journal: Cell death & disease

Published: March 06, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026